{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:35:26Z","timestamp":1792931726207,"version":"4.5.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.redox.2026.104410","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:13:54Z","timestamp":1790061234000},"page":"104410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antiglycation approach in selected autoimmune diseases: Where do we stand?"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-4737","authenticated-orcid":false,"given":"Szymon","family":"Dryga\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8372-2905","authenticated-orcid":false,"given":"Roman","family":"Cemaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-3187","authenticated-orcid":false,"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104410_bib1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2026.104410_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.redox.2026.104410_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.redox.2026.104410_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jhg.2015.94","article-title":"Genetics of autoimmune diseases: insights from population genetics","volume":"60","author":"Ramos","year":"2015","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.redox.2026.104410_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.redox.2026.104410_bib6","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI78088","article-title":"Mechanisms of human autoimmunity","volume":"125","author":"Rosenblum","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.redox.2026.104410_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2008.04.019","article-title":"Autoimmunity and oxidatively modified autoantigens","volume":"7","author":"Kurien","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.redox.2026.104410_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/physrev.00001.2019","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases","volume":"100","author":"Schalkwijk","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2026.104410_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrrheum.2017.37","article-title":"Metabolic regulation of inflammation","volume":"13","author":"Gaber","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib10","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.3390\/molecules25235591","article-title":"The development of maillard reaction, and advanced glycation end product (AGE)-Receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases","volume":"25","author":"Shen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2026.104410_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10753-021-01589-7","article-title":"AGE\/Non-AGE glycation: an important event in rheumatoid arthritis pathophysiology","volume":"45","author":"Monu","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.redox.2026.104410_bib12","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/ijms24032894","article-title":"The potential influence of advanced glycation end products and (s)RAGE in rheumatic diseases","volume":"24","author":"Delrue","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/08916930902831746","article-title":"AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis","volume":"42","author":"Nienhuis","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.redox.2026.104410_bib14","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1038\/s41598-018-27108-7","article-title":"Investigating the glycating effects of glucose, glyoxal and methylglyoxal on human sperm","volume":"8","author":"Nevin","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104410_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1489657","article-title":"\u03b2-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress","volume":"15","author":"Dryga\u0142a","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2026.104410_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117976","article-title":"Inhibition of protein glycation by vasodilatory \u03b2-blockers \u2013 in vitro studies and in silico analyses","volume":"185","author":"Dryga\u0142a","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2026.104410_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/3818196","article-title":"Advanced glycation end products (AGEs): Biochemistry, signaling, analytical methods, and epigenetic effects","volume":"2020","author":"Perrone","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2026.104410_bib18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104410_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","article-title":"Role of advanced glycation end products in cellular signaling","volume":"2","author":"Ott","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104410_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.redox.2026.104410_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3164\/jcbn.10-50","article-title":"Relationship between pentosidine and pyridinoline levels in human diabetic cataract lenses","volume":"47","author":"Hashimoto","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.redox.2026.104410_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13098-022-00895-w","article-title":"The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus","volume":"14","author":"Rezaei","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.redox.2026.104410_bib23","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.3390\/jcm10204792","article-title":"Glycation and glycosylation in cardiovascular remodeling: focus on advanced glycation end products and O-Linked glycosylations as glucose-related pathogenetic factors and disease markers","volume":"10","author":"Dozio","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.redox.2026.104410_bib24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/ajt.12368","article-title":"Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia\u2013reperfusion injury","volume":"13","author":"Sharma","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.redox.2026.104410_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.1900860","article-title":"Interplay between RAGE and TLR4 regulates HMGB1-Induced inflammation by promoting cell surface expression of RAGE and TLR4","volume":"205","author":"Zhong","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib26","first-page":"53","author":"Delrue","year":"2023"},{"key":"10.1016\/j.redox.2026.104410_bib27","first-page":"737","article-title":"Implication of RAGE polymorphic variants in COPD complication and Anti-COPD therapeutic potential of sRAGE","volume":"18","author":"Malik","year":"2021","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.redox.2026.104410_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09513590.2019.1633297","article-title":"sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation","volume":"36","author":"Wang","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.redox.2026.104410_bib29","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1021\/tx050074u","article-title":"Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins","volume":"18","author":"Zeng","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2026.104410_bib30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1039\/C6MT00235H","article-title":"Effect of Cu(ii) on in vitro glycation of human serum albumin by methylglyoxal: a LC-MS-based proteomic approach","volume":"9","author":"Ramirez Segovia","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.redox.2026.104410_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1262-3636(07)70183-0","article-title":"Albumin antioxidant capacity is modified by methylglyoxal","volume":"31","author":"Faure","year":"2005","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.redox.2026.104410_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0009-8981(00)00389-2","article-title":"Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus","volume":"303","author":"Turk","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.redox.2026.104410_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: Bridging association and causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104410_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/01.RES.0000103862.26506.3D","article-title":"Glycation, inflammation, and RAGE","volume":"93","author":"Yan","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2026.104410_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arr.2015.01.003","article-title":"DAMPs as mediators of sterile inflammation in aging-related pathologies","volume":"24","author":"Feldman","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.redox.2026.104410_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib37","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.3390\/ijms22136904","article-title":"Molecular characteristics of RAGE and advances in small-molecule inhibitors","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib38","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1021\/bi7003735","article-title":"The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units","volume":"46","author":"Dattilo","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2026.104410_bib39","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.str.2010.05.017","article-title":"Structural basis for ligand recognition and activation of RAGE","volume":"18","author":"Koch","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.redox.2026.104410_bib40","doi-asserted-by":"crossref","first-page":"27255","DOI":"10.1074\/jbc.M801622200","article-title":"Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE)","volume":"283","author":"Xie","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2026.104410_bib41","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/cb4001553","article-title":"Stable RAGE-heparan sulfate complexes are essential for signal transduction","volume":"8","author":"Xu","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.redox.2026.104410_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2026.104410_bib43","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.4049\/jimmunol.1002253","article-title":"Septic shock is associated with receptor for advanced glycation end products ligation of LPS","volume":"186","author":"Yamamoto","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2026.104190","article-title":"Protein glycoxidation in neuropsychiatric disorders-from basic research to clinical practice","volume":"94","author":"Orlof","year":"2026","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104410_bib45","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1096\/fj.07-9909com","article-title":"Identification, classification, and expression of RAGE gene splice variants","volume":"22","author":"Hudson","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2026.104410_bib46","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2026.104410_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101958","article-title":"The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes","volume":"42","author":"Erusalimsky","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104410_bib48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1476-5381.2012.01984.x","article-title":"RAGE: a new frontier in chronic airways disease","volume":"167","author":"Sukkar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2026.104410_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1347432","article-title":"Role of the soluble receptor for advanced glycation end products (sRAGE) as a prognostic factor for mortality in hemodialysis and peritoneal dialysis patients","volume":"2018","author":"Dozio","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.redox.2026.104410_bib50","article-title":"Serum level of soluble receptor for advanced glycation end products is associated with A disintegrin and metalloproteinase 10 in type 1 diabetes","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib51","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.3390\/molecules27154922","article-title":"Receptor for advanced glycation end products (RAGE): a pivotal hub in immune diseases","volume":"27","author":"Yue","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.redox.2026.104410_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7675286","article-title":"RAGE and TLRs as key targets for antiatherosclerotic therapy","volume":"2018","author":"Olejarz","year":"2018","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.redox.2026.104410_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions \u2013 a review","volume":"206","author":"Zhou","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2026.104410_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40001-021-00559-x","article-title":"Advanced glycosylation end products inhibit the proliferation of bone-marrow stromal cells through activating MAPK pathway","volume":"26","author":"Li","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.redox.2026.104410_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/ijmm.2023.5270","article-title":"Inflammation and coagulation abnormalities via the activation of the HMGB1-RAGE\/NF-\u03baB and F2\/Rho pathways in lung injury induced by acute hypoxia","volume":"52","author":"Gao","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.redox.2026.104410_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104410_bib57","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jcmm.17149","article-title":"Glycyrrhizin regulates rat TMJOA progression by inhibiting the HMGB1\u2010RAGE\/TLR4\u2010NF\u2010\u03baB\/AKT pathway","volume":"26","author":"Hu","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.redox.2026.104410_bib58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1139\/apnm-2019-0936","article-title":"Receptor for advanced glycation end products modulates oxidative stress and mitochondrial function in the soleus muscle of mice fed a high-fat diet","volume":"45","author":"Velayoudom-Cephise","year":"2020","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.redox.2026.104410_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160555","article-title":"RAGE activation in macrophages and development of experimental diabetic polyneuropathy","volume":"7","author":"Osonoi","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.redox.2026.104410_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11596-014-1224-1","article-title":"Advanced glycation end products promote differentiation of CD4+ T helper cells toward pro-inflammatory response","volume":"34","author":"Han","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib61","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.1600197","article-title":"The receptor for advanced glycation endproducts drives T cell survival and inflammation in type 1 diabetes mellitus","volume":"197","author":"Durning","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib62","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.redox.2026.104410_bib63","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.3390\/ijms141019891","article-title":"Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond","volume":"14","author":"Daffu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.996307","article-title":"HMGB1 is a mediator of cuproptosis-related sterile inflammation","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.redox.2026.104410_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00581","article-title":"Occurrence of a RAGE-mediated inflammatory response in human fetal membranes","volume":"11","author":"Choltus","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.redox.2026.104410_bib66","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3390\/antiox11061151","article-title":"Mitochondrial dysfunction and oxidative stress in rheumatoid arthritis","volume":"11","author":"L\u00f3pez-Armada","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104410_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1440313","article-title":"The antioxidant barrier, oxidative\/nitrosative stress, and protein glycation in allergy: from basic research to clinical practice","volume":"15","author":"Biedrzycki","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib68","article-title":"Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104410_bib70","article-title":"The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.redox.2026.104410_bib71","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.3390\/ijms25116162","article-title":"Mitochondrial dysfunction in systemic lupus erythematosus with a focus on lupus nephritis","volume":"25","author":"Halfon","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113722","article-title":"Mitochondria dysfunction: a trigger for cardiovascular diseases in systemic lupus erythematosus","volume":"144","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.redox.2026.104410_bib73","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/biom12091216","article-title":"Mitochondrial dysfunction in rheumatoid arthritis","volume":"12","author":"Ma","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2026.104410_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1432985","article-title":"Autoimmunity: the neoantigen hypothesis","volume":"15","author":"Mustelin","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib75","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.redox.2014.05.004","article-title":"Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases","volume":"2","author":"Ryan","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104410_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710131","article-title":"Sources of cancer neoantigens beyond single-nucleotide variants","volume":"23","author":"Capietto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104410_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijbiomac.2021.12.161","article-title":"Biophysical changes in methylglyoxal modified fibrinogen and its role in the immunopathology of type 2 diabetes mellitus","volume":"202","author":"Perween","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.redox.2026.104410_bib79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijbiomac.2016.02.019","article-title":"Neo-epitopes on methylglyoxal modified human serum albumin lead to aggressive autoimmune response in diabetes","volume":"86","author":"Jyoti","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.redox.2026.104410_bib80","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijbiomac.2021.01.197","article-title":"Methylglyoxal mediated glycation leads to neo-epitopes generation in fibrinogen: role in the induction of adaptive immune response","volume":"175","author":"Rehman","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.redox.2026.104410_bib81","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/iub.1375","article-title":"Fructosylation generates neo\u2010epitopes on human serum albumin","volume":"67","author":"Allarakha","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.redox.2026.104410_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172074","article-title":"Non-enzymatic glucosylation induced neo-epitopes on human serum albumin: a concentration based study","volume":"12","author":"Neelofar","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110147","article-title":"d-ribose-mediated glycation of fibrinogen: role in the induction of adaptive immune response","volume":"367","author":"Alouffi","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2026.104410_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.814155","article-title":"Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis","volume":"12","author":"Fasano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/imm.13298","article-title":"Nanoparticle\u2010mediated targeting of autoantigen peptide to cross\u2010presenting liver sinusoidal endothelial cells protects from CD8 T\u2010cell\u2010driven autoimmune cholangitis","volume":"162","author":"Carambia","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.redox.2026.104410_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1097871","article-title":"Immunogenic self-peptides - the great unknowns in autoimmunity: identifying T-cell epitopes driving the autoimmune response in autoimmune diseases","volume":"13","author":"Prinz","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib87","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1038\/s41467-023-42541-7","article-title":"Antigen presentation by B cells enables epitope spreading across an MHC barrier","volume":"14","author":"Fahlquist-Hagert","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2026.104410_bib88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2021.03.019","article-title":"Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases","volume":"70","author":"Streeter","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.redox.2026.104410_bib90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update \u03bfn the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.redox.2026.104410_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073980","article-title":"Advances in the management of systemic lupus erythematosus","volume":"383","author":"Morand","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.redox.2026.104410_bib92","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.redox.2026.104410_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-3083.2012.02691.x","article-title":"The plasma level of soluble receptor for advanced glycation end products is decreased in patients with systemic lupus erythematosus","volume":"75","author":"Ma","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109317","article-title":"Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps","volume":"250","author":"Watanabe","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib96","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.3390\/cells10123523","article-title":"Advanced glycation end-products (AGEs) and their soluble receptor (sRAGE) in women suffering from systemic lupus erythematosus (SLE)","volume":"10","author":"Nowak","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.redox.2026.104410_bib97","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/biom14040412","article-title":"The RAGE axis: a relevant inflammatory hub in human diseases","volume":"14","author":"Rojas","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2026.104410_bib98","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/rheumatology\/ken302","article-title":"Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts","volume":"47","author":"Nienhuis","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.redox.2026.104410_bib99","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/rheumatology\/kem215","article-title":"Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus","volume":"46","author":"de Leeuw","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.redox.2026.104410_bib100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/jpm11080693","article-title":"Cellular response against oxidative stress, a novel insight into lupus nephritis pathogenesis","volume":"11","author":"Ene","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.redox.2026.104410_bib101","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/ijms25053022","article-title":"Role of advanced glycation end products as new biomarkers in systemic lupus erythematosus","volume":"25","author":"Carri\u00f3n-Barber\u00e0","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib102","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/biomedicines12030610","article-title":"Serum advanced glycation end products and their soluble receptor as new biomarkers in systemic lupus erythematosus","volume":"12","author":"Carri\u00f3n-Barber\u00e0","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.redox.2026.104410_bib103","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3390\/antiox12081627","article-title":"Biomarkers of oxidative stress in systemic lupus erythematosus patients with active nephritis","volume":"12","author":"Liu","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104410_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102843","article-title":"Methylglyoxal suppresses microglia inflammatory response through NRF2-I\u03baB\u03b6 pathway","volume":"65","author":"Wei","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104410_bib105","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00296-023-05393-4","article-title":"Comparison of advanced glycation end products concentration in the skin among patients with rheumatic diseases, with and without comorbid depression: a case\u2013control study","volume":"43","author":"\u017buchowski","year":"2023","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.redox.2026.104410_bib106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12891-015-0569-3","article-title":"The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.redox.2026.104410_bib107","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/1871530320666200506082848","article-title":"Association between sRAGE and arterial stiffness in women with systemic lupus erythematosus","volume":"21","author":"Wang","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.redox.2026.104410_bib108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1546-0096-12-50","article-title":"The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus","volume":"12","author":"Bobek","year":"2014","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib109","first-page":"3450","article-title":"An investigation of the relationship between rheumatological diseases and soluble receptor for advanced glycation end products","volume":"26","author":"Okuyucu","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.redox.2026.104410_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.redox.2026.104410_bib112","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/imr.12986","article-title":"Fibroblast pathology in inflammatory joint disease","volume":"302","author":"Marsh","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.redox.2026.104410_bib113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.redox.2026.104410_bib114","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-022-02727-8","article-title":"Role of the S100 protein family in rheumatoid arthritis","volume":"24","author":"Wu","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib115","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/cimb46040228","article-title":"The role of alarmins in the pathogenesis of rheumatoid arthritis, osteoarthritis, and psoriasis","volume":"46","author":"Kie\u0142bowski","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.redox.2026.104410_bib116","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/rheumatology\/38.12.1275","article-title":"Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis","volume":"38","author":"Chen","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.redox.2026.104410_bib117","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00296-004-0518-1","article-title":"The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis","volume":"26","author":"Hein","year":"2005","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.redox.2026.104410_bib118","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.61.6.488","article-title":"Identification of the advanced glycation end products N\u03b5-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis","volume":"61","author":"Drinda","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.redox.2026.104410_bib119","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0004563217733500","article-title":"Increased serum concentrations of N \u025b -carboxymethyllysine are related to the presence and the severity of rheumatoid arthritis","volume":"55","author":"Knani","year":"2018","journal-title":"Ann. Clin. Biochem. Int. J. Lab. Med."},{"key":"10.1016\/j.redox.2026.104410_bib120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2474-11-83","article-title":"Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis","volume":"11","author":"Vyt\u00e1\u0161ek","year":"2010","journal-title":"BMC Muscoskelet. Disord."},{"key":"10.1016\/j.redox.2026.104410_bib121","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/6aan1g","article-title":"Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population based cohort","author":"Hinkema","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8735926","article-title":"Methylglyoxal: a relevant marker of disease activity in patients with rheumatoid arthritis","volume":"2018","author":"Knani","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.redox.2026.104410_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/ar3398","article-title":"The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1","volume":"13","author":"Heo","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib124","first-page":"740","article-title":"RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro","volume":"25","author":"Steenvoorden","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/clinchem\/44.2.250","article-title":"Increased concentrations of serum pentosidine in rheumatoid arthritis","volume":"44","author":"Rodr\u00edguez-Garc\u00eda","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.redox.2026.104410_bib126","doi-asserted-by":"crossref","first-page":"771","DOI":"10.33549\/physiolres.931147","article-title":"Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis","volume":"56","author":"Senolt","year":"2007","journal-title":"Physiol. Res."},{"key":"10.1016\/j.redox.2026.104410_bib127","doi-asserted-by":"crossref","DOI":"10.1186\/ar3538","article-title":"Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease","volume":"13","author":"de Groot","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib128","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar622","article-title":"Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis","volume":"5","author":"Newkirk","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib129","doi-asserted-by":"crossref","DOI":"10.1186\/ar1749","article-title":"Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control","volume":"7","author":"Pullerits","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib130","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar2645","article-title":"Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis","volume":"11","author":"Chen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.594622","article-title":"Low soluble receptor for advanced glycation end products precedes and predicts cardiometabolic events in women with rheumatoid arthritis","volume":"7","author":"Nadali","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.redox.2026.104410_bib132","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semarthrit.2012.07.002","article-title":"Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis\u2014A prospective study","volume":"42","author":"Tam","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.redox.2026.104410_bib133","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14397595.2018.1551107","article-title":"Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients","volume":"29","author":"Jafari Nakhjavani","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib134","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/03009742.2022.2042975","article-title":"NT-proBNP and sRAGE levels in early rheumatoid arthritis","volume":"52","author":"Heslinga","year":"2023","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.redox.2026.104410_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312729","article-title":"Are the soluble receptors sRAGE, sRANKL, and osteoprotegerin associated with anemia in rheumatoid arthritis?","volume":"25","author":"Stefanova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib136","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1038\/s41598-023-35098-4","article-title":"Integrative mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis","volume":"13","author":"Lee","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104410_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101809","article-title":"The beta cell-immune cell interface in type 1 diabetes (T1D)","volume":"78","author":"James","year":"2023","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2026.104410_bib138","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2026.104410_bib139","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00125-020-05105-8","article-title":"Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability","volume":"63","author":"Zhang","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104410_bib140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1196\/annals.1447.011","article-title":"Induction of apoptosis of beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus","volume":"1150","author":"Lim","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib141","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/diabetes.52.6.1441","article-title":"Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice","volume":"52","author":"Peppa","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib142","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s00125-011-2058-z","article-title":"Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes","volume":"54","author":"Forbes","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104410_bib143","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.2337\/db22-0177","article-title":"Soluble RAGE prevents type 1 diabetes expanding functional regulatory T cells","volume":"71","author":"Leung","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib144","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/dc14-1186","article-title":"Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes","volume":"38","author":"Salonen","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.redox.2026.104410_bib145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.20452\/pamw.1025","article-title":"Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes","volume":"121","author":"Samborski","year":"2011","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.redox.2026.104410_bib146","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/dia.2011.0043","article-title":"Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes","volume":"13","author":"Araszkiewicz","year":"2011","journal-title":"Diabetes Technol. Therapeut."},{"key":"10.1016\/j.redox.2026.104410_bib147","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabet.2009.11.003","article-title":"Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy","volume":"36","author":"Chabroux","year":"2010","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.redox.2026.104410_bib148","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s00125-006-0355-8","article-title":"Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes","volume":"49","author":"Yu","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104410_bib149","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/JOE-13-0407","article-title":"Advanced glycation end products are associated with arterial stiffness in type 1 diabetes","volume":"221","author":"Llaurad\u00f3","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.redox.2026.104410_bib150","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s13300-022-01285-1","article-title":"Association between the tissue and circulating advanced glycation end-products and the Micro- and macrovascular complications in type 1 diabetes: the DIABAGE study","volume":"13","author":"Diallo","year":"2022","journal-title":"Diab. Ther."},{"key":"10.1016\/j.redox.2026.104410_bib151","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc10-1087","article-title":"Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"34","author":"Nin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.redox.2026.104410_bib152","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2337\/dc13-3049","article-title":"Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes","volume":"37","author":"Salonen","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.redox.2026.104410_bib153","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/JPEM.2009.22.10.895","article-title":"Association between serum levels of the soluble receptor (sRAGE) for advanced glycation endproducts (AGEs) and their receptor (RAGE) in peripheral blood mononuclear cells of children with type 1 diabetes mellitus","volume":"22","author":"Dettoraki","year":"2009","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2026.104410_bib154","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.numecd.2014.10.009","article-title":"Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease","volume":"25","author":"Bakker","year":"2015","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.redox.2026.104410_bib155","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2337\/db09-1509","article-title":"Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"59","author":"Nin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib156","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00125-011-2186-5","article-title":"Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes","volume":"54","author":"Thomas","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2026.104410_bib157","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-024-01759-2","article-title":"Association between the soluble receptor for advanced glycation end products and diabetes mellitus: systematic review and meta-analysis","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.redox.2026.104410_bib158","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413570","article-title":"The RAGE pathway in skin pathology development: a comprehensive review of its role and therapeutic potential","volume":"25","author":"Radziszewski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib159","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1038\/jid.2013.185","article-title":"Keratinocyte-specific deletion of the receptor RAGE modulates the kinetics of skin inflammation in vivo","volume":"133","author":"Leibold","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.redox.2026.104410_bib160","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2340\/00015555-2661","article-title":"Advanced glycation end products are increased in the skin and blood of patients with severe psoriasis","volume":"97","author":"Papagrigoraki","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.redox.2026.104410_bib161","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/biom12121870","article-title":"Concentrations of N6-Carboxymethyllysine (CML), N6-Carboxyethyllysine (CEL), and soluble receptor for advanced glycation end-products (sRAGE) are increased in psoriatic patients","volume":"12","author":"Damasiewicz-Bodzek","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2026.104410_bib162","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00403-013-1362-5","article-title":"Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis","volume":"305","author":"Kaur","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.redox.2026.104410_bib163","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaut.2013.02.005","article-title":"High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis","volume":"43","author":"Robinson","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.redox.2026.104410_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095678","article-title":"The receptor for advanced glycation end products (RAGE) affects T cell differentiation in OVA induced asthma","volume":"9","author":"Akirav","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/ijms18020421","article-title":"Methylglyoxal-derived advanced glycation endproducts in multiple sclerosis","volume":"18","author":"Wetzels","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib166","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-2094-7-72","article-title":"Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis","volume":"7","author":"Sternberg","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.redox.2026.104410_bib167","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5114\/aoms.2020.95654","article-title":"Carboxymethyllysine and carboxyethyllysine in multiple sclerosis patients","volume":"20","author":"Damasiewicz-Bodzek","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib168","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00855","article-title":"Methylglyoxal-derived advanced glycation endproducts accumulate in multiple sclerosis lesions","volume":"10","author":"Wetzels","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib169","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41385-018-0119-z","article-title":"The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for inflammatory bowel diseases","volume":"12","author":"Body-Malapel","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib170","article-title":"S100A4 contributes to colitis development by increasing the adherence of Citrobacter rodentium in intestinal epithelial cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104410_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1746.2008.05552.x","article-title":"Increased pentosidine, an advanced glycation end\u2010product, in urine and tissue reflects disease activity in inflammatory bowel diseases","volume":"23","author":"Kato","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2026.104410_bib172","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.crohns.2011.03.011","article-title":"Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity","volume":"5","author":"Yilmaz","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.redox.2026.104410_bib173","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/antiox8090378","article-title":"Analysis of oxidative stress-related markers in Crohn's disease patients at surgery and correlations with clinical findings","volume":"8","author":"Luceri","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104410_bib174","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/nu15040882","article-title":"Impact of preoperative immunonutrition on oxidative stress and gut barrier function in surgical patients with Crohn's disease","volume":"15","author":"Bigagli","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2026.104410_bib175","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.3748\/wjg.v19.i45.8269","article-title":"Role of the advanced glycation end products receptor in Crohn's disease inflammation","volume":"19","author":"Ciccocioppo","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2026.104410_bib176","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/antiox14040492","article-title":"Advanced glycation end products in disease development and potential interventions","volume":"14","author":"Zhang","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104410_bib177","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/microorganisms10091848","article-title":"Advanced glycation end products in health and disease","volume":"10","author":"Reddy","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.redox.2026.104410_bib178","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/labinvest.2014.42","article-title":"Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling","volume":"94","author":"Tang","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.redox.2026.104410_bib179","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3892\/mmr.2015.4725","article-title":"Curcumin inhibits advanced glycation end product-induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal","volume":"13","author":"Sun","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.redox.2026.104410_bib180","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/labinvest.2012.53","article-title":"Curcumin eliminates the inhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor-1 in hepatic stellate cells in vitro","volume":"92","author":"Lin","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.redox.2026.104410_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111559","article-title":"Oral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NF\u03baB signaling and macrophage migration","volume":"9","author":"Young","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib182","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1002\/jcb.28488","article-title":"Nanocurcumin: a novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function","volume":"120","author":"Hajialilo","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.redox.2026.104410_bib183","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/nu11051004","article-title":"Curcumin in autoimmune and rheumatic diseases","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2026.104410_bib184","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/ptr.7417","article-title":"Immunomodulatory effects of curcumin in systemic autoimmune diseases","volume":"36","author":"Chamani","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.redox.2026.104410_bib185","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/db11-1120","article-title":"Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications","volume":"61","author":"Nagai","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib186","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2174\/138161208784139684","article-title":"The role of AGEs in cardiovascular disease","volume":"14","author":"Jandeleit-Dahm","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.redox.2026.104410_bib187","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbadis.2006.02.004","article-title":"Comparison of protective effects of aspirin, d-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells","volume":"1762","author":"Zhang","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.redox.2026.104410_bib188","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190509","article-title":"Drug repurposing: In-vitro anti-glycation properties of 18 common drugs","volume":"13","author":"Rasheed","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib189","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.amjhyper.2004.08.022","article-title":"Advanced glycation end-product cross-link breakersA novel approach to cardiovascular pathologies related to the aging process","volume":"17","author":"Bakris","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.redox.2026.104410_bib190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cardfail.2004.09.010","article-title":"The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure","volume":"11","author":"Little","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.redox.2026.104410_bib191","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104410_bib192","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0006-2952(99)00263-4","article-title":"Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation","volume":"58","author":"Ruggiero-Lopez","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2026.104410_bib193","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1021\/acs.chemrestox.5b00497","article-title":"Metformin scavenges methylglyoxal to form a novel imidazolinone metabolite in humans","volume":"29","author":"Kinsky","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.redox.2026.104410_bib194","first-page":"1","article-title":"Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE\/NF \u03ba B pathway suppression","volume":"2016","author":"Zhou","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.redox.2026.104410_bib195","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.2174\/092986711796391552","article-title":"Antioxidant properties and associated mechanisms of salicylates","volume":"18","author":"Baltazar M","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.redox.2026.104410_bib196","article-title":"Investigating the antioxidant activity of metformin hydrochloride (MtHCl): theoretical intuitions and experimental evidences","volume":"2","author":"Safna","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.redox.2026.104410_bib197","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","article-title":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes","volume":"48","author":"Beisswenger","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib198","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","article-title":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis","volume":"182","author":"Nath","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/973986","article-title":"Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis","volume":"2014","author":"Son","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.redox.2026.104410_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100210","article-title":"Metformin-induced activation of Ca2+ signaling prevents immune infiltration\/pathology in Sjogren's syndrome-prone mouse models","volume":"7","author":"Nascimento Da Conceicao","year":"2023","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.redox.2026.104410_bib201","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/ijms24010755","article-title":"Metformin and its immune-mediated effects in various diseases","volume":"24","author":"Nojima","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2026.104410_bib202","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1100\/tsw.2010.104","article-title":"Thiol redox transitions in cell signaling: a lesson from N-Acetylcysteine","volume":"10","author":"Parasassi","year":"2010","journal-title":"Sci. World J."},{"key":"10.1016\/j.redox.2026.104410_bib203","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226696","article-title":"N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose\/high palmitic acid treatment in pancreatic Rin-5F cells","volume":"14","author":"Alnahdi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib204","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1159\/000458734","article-title":"Inhibition of methylglyoxal-induced AGEs\/RAGE expression contributes to dermal protection by N-Acetyl-L-Cysteine","volume":"41","author":"Yang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.redox.2026.104410_bib205","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear Factor-\u03baB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000099244","article-title":"Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats","volume":"39","author":"Yamagishi","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.redox.2026.104410_bib207","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00723","article-title":"N-acetylcysteine counteracts adipose tissue macrophage infiltration and insulin resistance elicited by advanced glycated albumin in healthy rats","volume":"8","author":"da Silva","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.redox.2026.104410_bib208","article-title":"Antioxidants inhibit advanced glycosylation end-product-induced apoptosis by downregulation of miR-223 in human adipose tissue-derived stem cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104410_bib209","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000421","article-title":"The receptor for advanced glycation endproducts (RAGE) and mediation of inflammatory neurodegeneration","author":"Derk","year":"2018","journal-title":"J. Alzheimers Dis. Parkinsonism"},{"key":"10.1016\/j.redox.2026.104410_bib210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/biomedicines11041131","article-title":"RAGE inhibitors in neurodegenerative diseases","volume":"11","author":"Reddy","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.redox.2026.104410_bib211","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/ddr.21971","article-title":"Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors","volume":"83","author":"Singh","year":"2022","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.redox.2026.104410_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00460","article-title":"Alarmin HMGB1 and soluble RAGE as new tools to evaluate the risk stratification in patients with the antiphospholipid syndrome","volume":"10","author":"Manganelli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104410_bib213","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000075627","article-title":"Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy","volume":"24","author":"Bolton","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.redox.2026.104410_bib214","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1159\/000108104","article-title":"Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy","volume":"27","author":"Williams","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.redox.2026.104410_bib215","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc06-0531","article-title":"Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes","volume":"29","author":"Stirban","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.redox.2026.104410_bib216","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040427","article-title":"Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy","volume":"7","author":"Alkhalaf","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2026.104410_bib217","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00726-018-2592-9","article-title":"Carnosine and advanced glycation end products: a systematic review","volume":"50","author":"Ghodsi","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.redox.2026.104410_bib218","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nutres.2017.11.003","article-title":"l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-\u03b1 levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial","volume":"49","author":"Houjeghani","year":"2018","journal-title":"Nutr. Res."},{"key":"10.1016\/j.redox.2026.104410_bib219","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.2337\/db16-0153","article-title":"Improved glycemic control and vascular function in overweight and Obese subjects by glyoxalase 1 inducer formulation","volume":"65","author":"Xue","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2026.104410_bib220","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7450514","article-title":"\u03b1-Lipoic acid strengthens the antioxidant barrier and reduces oxidative, nitrosative, and glycative damage, as well as inhibits inflammation and apoptosis in the hypothalamus but not in the cerebral cortex of insulin-resistant rats","volume":"2022","author":"Maciejczyk","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2026.104410_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13020438","article-title":"Alpha-lipoic acid treatment reduces the levels of advanced end glycation products in type 2 diabetes patients with neuropathy","volume":"13","author":"Csiha","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.redox.2026.104410_bib222","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1021\/jf504132x","article-title":"Quercetin inhibits advanced glycation end product formation by trapping methylglyoxal and glyoxal","volume":"62","author":"Li","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.redox.2026.104410_bib223","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/biof.1531","article-title":"The impact of resveratrol on toxicity and related complications of advanced glycation end products: a systematic review","volume":"45","author":"Hajizadeh-Sharafabad","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.redox.2026.104410_bib224","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/dme.12166","article-title":"Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)","volume":"30","author":"Lam","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.redox.2026.104410_bib225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/brainsci11081021","article-title":"The assessment of serum concentrations of AGEs and their soluble receptor (sRAGE) in multiple sclerosis patients","volume":"11","author":"Damasiewicz-Bodzek","year":"2021","journal-title":"Brain Sci."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172600409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172600409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:14:54Z","timestamp":1792930494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172600409X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":225,"alternative-id":["S221323172600409X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104410","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiglycation approach in selected autoimmune diseases: Where do we stand?","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104410"}}